Belite Bio, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public, Subsidiary
- Employees
- 20
- Market Cap
- $1.4B
- Website
- http://www.belitebio.com
Clinical Trials
13
Active:6
Completed:1
Trial Phases
3 Phases
Phase 1:6
Phase 2:1
Phase 3:5
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (12 trials with phase data)• Click on a phase to view related trials
Phase 1
6 (50.0%)Phase 3
5 (41.7%)Phase 2
1 (8.3%)A Phase 2/3 Study to Evaluate the Efficacy and Safety of Tinlarebant in Subjects With Stargardt Disease
- First Posted Date
- 2024-04-29
- Last Posted Date
- 2025-07-16
- Lead Sponsor
- Belite Bio, Inc
- Target Recruit Count
- 60
- Registration Number
- NCT06388083
- Locations
- 🇺🇸
Belite Study Site - US08, Phoenix, Arizona, United States
🇺🇸Belite Study Site - US05, La Jolla, California, United States
🇺🇸Belite Study Site - US09, San Francisco, California, United States
Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Geographic Atrophy
- First Posted Date
- 2023-07-18
- Last Posted Date
- 2025-02-14
- Lead Sponsor
- Belite Bio, Inc
- Target Recruit Count
- 429
- Registration Number
- NCT05949593
- Locations
- 🇬🇧
Belite Study Site, London, United Kingdom
Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Adolescent Stargardt Disease
Phase 3
Active, not recruiting
- Conditions
- Stargardt Disease 1
- Interventions
- Drug: Placebo
- First Posted Date
- 2022-02-17
- Last Posted Date
- 2024-06-07
- Lead Sponsor
- Belite Bio, Inc
- Target Recruit Count
- 104
- Registration Number
- NCT05244304
- Locations
- 🇬🇧
Belite Study Site, Southampton, United Kingdom
Safety and Tolerability of Escalating Doses of BPN-14967 in Healthy Adults
- First Posted Date
- 2019-07-02
- Last Posted Date
- 2021-06-18
- Lead Sponsor
- Belite Bio, Inc
- Target Recruit Count
- 40
- Registration Number
- NCT04005807
- Locations
- 🇺🇸
PPD Phase I Clinic, Austin, Texas, United States
News
No news found